- Life Sciences
- Conference
BioTechX USA 2024
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 2024 congress of BioTechX USA and present how Tempus leverages AI for RWE generation to support drug development.
Harnessing AI with Multimodal Data to Transform Drug Development
Discover how layering ML and AI on multimodal data can drive insights and propel various stages of drug discovery and development. Dive into Tempus' expertise in leveraging real-world data for novel target discovery, clinical trial optimization, translational research, and evidence generation. Join us to explore how AI is rapidly evolving to deliver value in advancing precision medicine and enhancing patient outcomes.
Kate Sasser, PhD Chief Scientific Officer (Tempus)
Learn more↗Schedule a meeting with us
We'll be in touch shortly.